Among the 34 galectin-3-negative microfollicular/solid lesions, 13 were histologically classified as follicular adenomas (39.3%), 20 as nodular hyperplasias (58.8%) and one as follicular carcinoma. Here, LGALS3 is linked to thyroid gland follicular carcinoma.